Piramal Pharma plunges 48% since listing on selling pressure - Business News: Latest News & Videos about market and economy | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Piramal Pharma plunges 48% since listing on selling pressure

Piramal Pharma is currently trading at valuations of 31.4 times FY23 estimated earnings and 17 times FY23 estimated EV/EBITDA.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...

Post Top Ad